首页> 外文期刊>Pharmacy Practice >Medication dispensing, additional therapeutic recommendations, and pricing practices for acute diarrhoea by community pharmacies in Germany: a simulated patient study
【24h】

Medication dispensing, additional therapeutic recommendations, and pricing practices for acute diarrhoea by community pharmacies in Germany: a simulated patient study

机译:通过德国社区药房的急性腹泻的药物分配,额外的治疗建议和定价实践:模拟患者研究

获取原文
           

摘要

Background: In Germany over-the-counter medications (OTC) – which since 2004 are no longer subject to binding prices – can only be purchased in pharmacies. Pharmacy owners and their staff therefore have a special responsibility when dispensing, advising on and setting the prices of medications. Objective: The aim of this study was to assess medication dispensing, additional therapeutic recommendations and pricing practices for acute diarrhoea in adults and to evaluate the role of the patient’s approach (symptom-based versus medication-based request) in determining the outcome of these aspects. Methods: A cross-sectional study was conducted from 1 May to 31 July 2017 in all 21 community pharmacies in a medium-sized German city. Symptom-based and medication-based scenarios related to self-medication of acute diarrhoea were developed and used by five simulated patients (SPs) in all of the pharmacies (a total of 84 visits). Differentiating between the different test scenarios in terms of the commercial and active ingredient names and also the prices of the medications dispensed, the SPs recorded on collection forms whether the scenario involved generic products or original preparations as well as whether recommendations were made during the test purchases regarding an additional intake of fluids. Results: In each of the 84 test purchases one preparation was dispensed. However, a preparation for oral rehydration was not sold in a single test purchase. On the other hand, in 74/84 (88%) of test purchases, medications with the active ingredient loperamide were dispensed. In only 35/84 (42%) of test purchases, the patient was also recommended to ensure an ‘adequate intake of fluids’ in addition to being dispensed a medication. In symptom-based scenarios significantly more expensive medications were dispensed compared to the medication-based scenarios (Wilcoxon signed rank test: z = -4.784, p 0.001, r = 0.738). Also within the different scenarios there were enormous price differences identified – for example, in the medication-based scenarios, even for comparable loperamide generics the cheapest preparation cost EUR 1.99 and the most expensive preparation cost EUR 4.53. Conclusions: Oral rehydration was not dispensed and only occasionally was an adequate intake of fluids recommended. There were also enormous price differences both between and within the scenarios investigated.
机译:背景:在德国过度柜台药物(OTC) - 自2004年以来不再符合约束价 - 只能在药房中购买。因此,药房所有者在分配,建议和设定药物价格时具有特别责任。目的:本研究的目的是评估成人中急性腹泻的药物分配,额外的治疗建议和定价实践,并评估患者方法的作用(症状为基于药物的提法的请求)确定这些方面的结果。方法:在2017年5月1日至2017年7月31日,在中型德国城市的所有21个社区药房中进行了横截面研究。在所有药房中的五种模拟患者(SPS)开发并使用了与自我用药相关的症状和基于药物的情景,其中包括所有药房(共84次访问)。在商业和活性成分名称方面的不同测试场景之间的区分以及分配药物的价格,在收集时录制的SPS表明情景是否涉及通用产品或原始准备,以及在测试期间是否进行了建议关于额外的流体摄入量。结果:在84个测试中的每一个中,分配了一种准备。然而,在单一测试购买中未销售口服补液的制备。另一方面,在74/84(88%)的试验购买中,分配了具有活性成分洛哌酰胺的药物。仅在测试购买的35/84(42%)中,还建议患者确保除了分配药物外,还要确保“充分摄入流体”。在症状的情况下,与基于药物的情况相比,分配了更昂贵的药物(Wilcoxon签名等级试验:Z = -4.784,P <0.001,R = 0.738)。同样在不同的情景中,确定了巨大的价格差异 - 例如,在基于药物的情景中,即使对于可比的洛哌米德普通,即使是相当的洛哌米德泛型,最便宜的准备成本1.99欧元,最昂贵的准备成本4.53欧元。结论:没有分配口腔补液,偶尔仅推荐的液体摄入量。在调查的情景之间也有巨大的价格差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号